Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.1 Agreement and Plan of Merger and Reorganization Among Malo Holdings Corporation, a Delaware Corporation, August Acquisition Corp, a Delaware Corporation, and Augmedix, Inc., a Delaware Corporation
- 3.1 Certificate of Merger Relating to the Merger of Acquisition Sub with and into Augmedix, Inc., Filed with the Secretary of State of the State of Delaware on October 5, 2020
- 3.2 Restated Certificate of Incorporation, Filed with the Secretary of State of the State of Delaware on October 5, 2020
- 3.3 Restated Bylaws
- 4.1 Warrant Agreement Dated June 11, 2015, by and Between Augmedix, Inc. and Comerica Bank
- 4.2 Warrant Agreement Dated July 28, 2017, by and Between Augmedix, Inc. and Comerica Bank
- 4.3 Warrant Agreement Dated August 28, 2018, by and Between Augmedix, Inc. and Dignity Health
- 4.4 Form of 2019 Series B Warrant Agreement
- 4.5 Warrant Agreement Dated August 7, 2019, by and Between Augmedix, Inc. and Partap Krishan Aggarwal
- 4.6 Warrant Agreement Dated September 3, 2019, by and Between Augmedix, Inc. and Trinity Capital Fund III, L.P
- 4.7 Form of Placement Agent Warrant Agreement
- 10.1 2013 Equity Incentive Plan and Form of Award Agreements
- 10.2 2020 Equity Incentive Plan and Form of Award Agreements
- 10.3 Offer Letter, Dated October 12, 2018, by and Between Emmanuel Krakaris and Augmedix, Inc.
- 10.4 Offer Letter, Dated March 7, 2019, by and Between Sandra Breber and Augmedix, Inc.
- 10.5 Offer Letter, Dated August 9, 2017, by and Between Matteo Marchetta and Augmedix, Inc.
- 10.6 Form of Indemnity Agreement (Directors and Executive Officers)
- 10.7 Form of Pre-merger Indemnification Agreement (Directors and Executive Officers)
- 10.8 Registration Rights Agreement, Dated October 5, 2020, by and Between Augmedix, Inc. and the Parties Thereto
- 10.9 Subscription Agreement, Dated October 5, 2020, by and Between Augmedix, Inc. and the Parties Thereto
- 10.10 Master Services Agreement, Dated October 1, 2019, by and Between Augmedix, Inc. and Ids Infotech Limited, an Indian Limited Company, As Amended
- 10.11 Master Services Agreement, Dated February 1, 2018, by and Between Augmedix, Inc. and Infosense Technologies, PVT. LTD. (Dba Og Healthcare), an Indian Limited Company, As Amended
- 10.12 Master Services Agreement, Dated April 15, 2015, by and Between Augmedix, Inc. and Sutter Health, a California Nonprofit Public Benefit Corporation, As Amended
- 10.13 Services Agreement, Dated September 1, 2015, by and Between Augmedix, Inc. and Dignity Health, a California Nonprofit Public Benefit Corporation, As Amended
- 10.14 Loan and Security Agreement, Dated June 11, 2015, by and Between Comerica Bank, Inc. and Augmedix, Inc., As Amended
- 10.15 Loan and Security Agreement, Dated May 31, 2017, by and Between Trinity Capital Fund III, L.P. a Delaware Limited Partnership and Augmedix, Inc.
- 10.16 Promissory Note, Dated April 5, 2020, by and Between East West Bank, Inc. and Augmedix, Inc.
- 10.17 Lease, Dated February 5, 2014, by and Between Augmedix, Inc. and DP Mission Street, LLC
- 16.1 Letter from Raich Ende Malter & Co. LLP As to the Change In Certifying Accountant, Dated As of October 8, 2020
- 21.1 Subsidiaries of the Registrant
- 99.1 Audited Financial Statements of Augmedix, Inc. As of and for the Fiscal Years Ended December 31, 2019 and 2018
- 99.2 Unaudited Financial Statements of Augmedix, Inc. As of and for the Quarterly Period Ended June 30, 2020
- 99.3 Unaudited Pro Forma Combined Financial Statements As of and for the Fiscal Year Ended December 31, 2019
- 99.4 Press Release Dated October 6, 2020
AUGX similar filings
Filing view
External links
Exhibit 16.1
175 Broadhollow Road, Suite 250 Melville, NY 11747 516.228.9000 516.228.9122 (fax) cpa@rem-co.com | 1375 Broadway, 15th Floor New York, New York 10018 212.944.4433 212.944.5404 (fax) | |
CERTIFIED PUBLIC ACCOUNTANTS & ADVISORS | Offices in New York City, Long Island & New Jersey |
October 8, 2020
Securities and Exchange Commission
100 F Street NE
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the section under the heading “Changes in Registrant’s Certifying Accountant” included in the Form 8-K of Augmedix, Inc. to be filed on or about October 9, 2020 and agree with the statements contained therein as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
Respectfully submitted,
/s/ Raich Ende Malter & Co. LLP
Melville, New York